Skip to content

Smart Ankle-Foot Orthosis to Improve Stroke Outcomes: Smart AFO

Smart Ankle-Foot Orthosis to Improve Stroke Outcomes: Smart AFO

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05619484
Enrollment
50
Registered
2022-11-17
Start date
2022-08-15
Completion date
2024-08-31
Last updated
2023-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

ankle-foot orthosis, orthotist

Brief summary

The Smart Ankle-Foot Orthosis (Smart AFO) system is an investigational system that combines a diagnostic ankle-foot orthosis with a mobile application to assist clinicians in optimizing an AFO user's gait by adjusting AFO stiffness and range of motion settings, and quantifying functional walking improvements in post-stroke individuals. The purpose of the clinical testing is to evaluate the Smart AFO system with its target users: post-stroke AFO users and orthotists. This may include, but is not limited to, identifying any aspects of the Smart AFO system that could be improved through clinical testing and evaluating the gait of post-stroke AFO users walking with an AFO adjusted using the Smart AFO system.

Interventions

DEVICESmart AFO

Diagnostic ankle-foot orthosis with AFO stiffness and range of motion settings adjusted using a mobile application

Sponsors

Becker Orthopedic
CollaboratorUNKNOWN
University of Utah
CollaboratorOTHER
Orthocare Innovations, LLC
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older * Mass less than 90 kg (200 lbs) * At least six months post-stroke * Hemiplegia or hemiparesis as a result of stroke * Foot drop during swing phase (often identified by a toe catch), on at least one side * Current user of an AFO * Current user of an AFO with a Triple Action Joint is acceptable * Has bilateral passive ankle range of motion within normal limits * Able to walk safely on level ground for at least 100 feet without rest * Able to communicate individual perceptions in the English language * Able to provide written informed consent * Participants that will use a treadmill during data collection must also be able to walk independently and safely on an instrumented treadmill

Exclusion criteria

* Confounding injury, musculoskeletal issues, or cognitive issues that limit effective participation * Pregnancy * Not able to read and understand English * Use of assistive device that requires bilateral upper extremities

Design outcomes

Primary

MeasureTime frameDescription
Ankle powerAssessed on day 1 (data collection day) with prescribed AFOAverage peak ankle joint power during stance phase (Newton-meters/second)
Timed Up and Go (TUG) testAssessed on day 1 (data collection day) with prescribed AFOThe Timed Up and Go (TUG) test is a validated timed functional test that involves standing up from a chair, walking forward for 3 meters, turning around, walking back to the chair for 3 meter, and sitting down. Measured in seconds.
Ankle plantarflexionAssessed on day 1 (data collection day) with prescribed AFOAverage ankle joint angle at foot flat after initial contact (degrees)
Ankle dorsiflexionAssessed on day 1 (data collection day) with prescribed AFOAverage ankle joint angle during midswing (degrees)
Knee angleAssessed on day 1 (data collection day) with prescribed AFOAverage knee joint angle at midstance (degrees)
Knee powerAssessed on day 1 (data collection day) with prescribed AFOAverage knee joint power at foot flat after initial contact (Newton-meters/second)

Secondary

MeasureTime frameDescription
Stride lengthAssessed on day 1 (data collection day) with prescribed AFOAverage stride length of steps (meters)

Countries

United States

Contacts

Primary ContactAdam Arabian
arabian@orthocareinnovations.com1-425-771-0797

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026